Serum from COVID-19 patients promotes endothelial cell dysfunction through protease-activated receptor 2

ConclusionOur findings provide the rationale for further studies to evaluate whether targeting PAR-2 may be a clinically effective strategy to counteract endothelial dysfunction in COVID-19.

Source: Inflammation Research - December 20, 2023 Category: Research Source Type: research